Why insider trading matters?

When insiders buy shares on the open market, this can thus be regarded as a strong endorsement by those that know the company the best -- they are literally betting their own money on the company's future. Insider selling, however, is not necessarily meaningful in any way, as there is a range of reasons for insiders to liquidate (some) of the shares they own.

- Seeking Alpha
Radius Health, Inc. (RDUS)
Sector: Healthcare; Industry: Drug Manufacturers—Specialty & Generic

Radius Health, Inc., a biopharmaceutical company, develops and commercializes endocrine therapeutics in the areas of osteoporosis and oncology. The company has collaborations and license agreements with 3M Company; Ipsen Pharma SAS; Eisai Co. Ltd.; Duke University; and Teijin Limited.


Trade Date Insider Title Buy/Sell #Shares Price Value Option
2020-02-26 Kelly Joseph Francis Sr. VP of Sales and Marketing Sell 889 $17.93 $15,942 No
2019-06-07 Kelly Joseph Francis Sr. VP of Sales and Marketing Buy 2,500 $21.81 $54,536 No
2019-05-10 Kelly Joseph Francis Sr. VP of Sales and Marketing Buy 2,000 $21.43 $42,860 No
2018-12-17 Kelly Joseph Francis Sr. VP of Sales and Marketing Buy 3,000 $15.71 $47,130 No

Insider Smart

Celldex Therapeutics, Inc. (CLDX) - Multiple insiders including President, EVP, CEO, CSO and Directors bought shares on Jun.9th, first time since 2018, this was very convincing and we initiated a position. Stock soared from $3 to 9$ in 2 days, and the run is still going on.

Insider Smart

Mohawk Group Holdings, Inc. (MWK) - Multiple insiders bought MWK in June around $5, stock moved sideways for a month then made a 60% jump in 10 days. Patience is the key.